In the fight against multi-resistant bacteria, bacteriophages—the natural enemies of bacteria—are attracting increasing research interest. However, the targeted therapeutic application of these “bacterial killers”...
Bacteriophages are viruses that specifically attack bacteria but are harmless to humans. They attach themselves to bacteria, inject their genetic material, and reprogram the cells so that they only produce phage genetic...
The Helmholtz Centre for Infection Research (HZI) in Braunschweig succeeded with three project proposals in the zukunft.niedersachsen funding program of the Lower Saxony Ministry of Science and Culture (MWK) and the...
Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Centre for Individualised Infection Medicine (CiiM) investigated...
The former President of Hannover Medical School (MHH) and Clinical Director of the Helmholtz Centre for Infection Research (HZI), Prof. Michael P. Manns, passed away on 15 August 2025. Manns succumbed to a tumor disease...
A balanced gut microbiome not only contributes to digestion, but is also an important protective factor against infections. Researchers at the Helmholtz Centre for Infection Research (HZI) led by Prof. Till Strowig,...
Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants that are predicted...
The Friends of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Technische Universität Braunschweig are awarding Prof. Richmond Sarpong from the University of California, Berkeley, with the...
The German Research Foundation (DFG) is funding the DEEP-DV research group for another four years with a total of €5.3 million. This marks the second phase of the successful work of the interdisciplinary group, which...
